Therapy for Dupuytren’s Disease (II): Collagenase Therapy vs. Limited Fasciectomy—A Long-Term Comparative Study
The two therapy options should be seen as complementary for the treatment of DD. Collagenase therapy seems a sensible option for DD with an earlier Tubiana stage and contractures that predominantly affect the MCP joint. Contractures with higher Tubiana stages that also affect the PIP joint should predominantly be treated with limited fasciectomy.
Authors
- Verena Alt
- Nikolaus Wachtel (ORCID: https://orcid.org/0000-0003-3746-7838)
- Nicholas Moellhoff (ORCID: https://orcid.org/0000-0002-1059-5840)
- Wolfram Demmer (ORCID: https://orcid.org/0000-0001-7893-3976)
- Constanze Kuhlmann (ORCID: https://orcid.org/0000-0002-8102-1430)
- Elisabeth Maria Haas-Lützenberger (ORCID: https://orcid.org/0000-0003-0458-4122)
- Riccardo E. Giunta (ORCID: https://orcid.org/0009-0007-7421-1213)
- Sinan Mert (ORCID: https://orcid.org/0009-0004-1244-5469)
- Francesca Romana Dingler
Institutions
- LMU Klinikum (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Life
- Published
- 2025-01-10
- DOI
- https://doi.org/10.3390/life15010076
- Primary Topic
- Dupuytren's Contracture and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00